Proteomic and metabolomic analysis of atrial profibrillatory remodelling in congestive heart failure

Journal of Molecular and Cellular Cardiology

Volumn 49, Issue 5, 2010, Pages 851-863

  De Souza, Ayesha I ^a   Cardin, Sophie ^b   Wait, Robin ^c   Chung, Yuen Li ^a,d   Vijayakumar, Meeraa ^a   Maguy, Ange ^b   Camm, A John ^a   Nattel, Stanley ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b MONTREAL HEART INSTITUTE   (Canada)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Atrial fibrillation; Congestive heart failure; Metabolomics; Proteomics; Remodelling

Indexed keywords

2 OXOISOVALERIC ACID; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALANINE; ALPHA B CRYSTALLIN; ALPHA CRYSTALLIN; ALPHA ENOLASE; BETA ENOLASE; DESMIN; ENOLASE; FILAMIN; GLUCOSE; GLUCOSE REGULATED PROTEIN 78; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; MALATE DEHYDROGENASE; PEROXIREDOXIN; PYRUVATE DEHYDROGENASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOWN REGULATION; ELECTRON MICROSCOPY; EXPERIMENTAL DOG; GLYCOLYSIS; HEART ATRIUM FIBRILLATION; HEART MUSCLE CELL; HEART MUSCLE METABOLISM; HEART PROTECTION; HEART VENTRICLE REMODELING; HIGH THROUGHPUT SCREENING; METABOLIC STRESS; METABOLOMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEOMICS; SHAM PROCEDURE; STEADY STATE; STRUCTURE ANALYSIS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

ANIMALS; ANTIOXIDANTS; ATRIAL FIBRILLATION; BLOTTING, WESTERN; CONTRACTILE PROTEINS; DOGS; ELECTROPHYSIOLOGICAL PHENOMENA; HEART FAILURE; HEAT-SHOCK PROTEINS; HEMODYNAMICS; METABOLOMICS; MYOCARDIUM; MYOCYTES, CARDIAC; PROTEOMICS; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

CANIS FAMILIARIS;

EID: 77957232646     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.07.008     Document Type: Article

References (55)

1. Lloyd-Jones D.M., Wang T.J., Leip E.P., Larson M.G., Levy D., Vasan R.S., et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004, 110:1042-1046.
2. Heeringa J., van der Kuip D.A., Hofman A., Kors J.A., van Herpen G., Stricker B.H., et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006, 27:949-953.
3. Miyasaka Y., Barnes M.E., Gersh B.J., Cha S.S., Bailey K.R., Abhayaratna W.P., et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006, 114:119-125.
4. Steinberg J.S. Atrial fibrillation: an emerging epidemic?. Heart 2004, 90:239-240.
5. Wijffels M.C., Kirchhof C.J., Dorland R., Allessie M.A. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995, 92:1954-1968.
6. Li D., Fareh S., Leung T.K., Nattel S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 1999, 100:87-95.
7. Yue L., Feng J., Gaspo R., Li G.R., Wang Z., Nattel S. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res 1997, 81:512-525.
8. Cardin S., Libby E., Pelletier P., Le Bouter S., Shiroshita-Takeshita A., Le Meur N., et al. Contrasting Gene Expression Profiles in Two Canine Models of Atrial Fibrillation. Circ Res 2007, 100:425-433.
9. De Souza A.I., Wait R., Mitchell A.G., Banner N.R., Dunn M.J., Rose M.L. Heat shock protein 27 is associated with freedom from graft vasculopathy after human cardiac transplantation. Circ Res 2005, 97:192-198.
10. Weekes J., Wheeler C.H., Yan J.X., Weil J., Eschenhagen T., Scholtysik G., et al. Bovine dilated cardiomyopathy: proteomic analysis of an animal model of human dilated cardiomyopathy. Electrophoresis 1999, 20:898-906.
11. Wait R., Gianazza E., Eberini I., Sironi L., Dunn M.J., Gemeiner M., et al. Proteins of rat serum, urine, and cerebrospinal fluid: VI. Further protein identifications and interstrain comparison. Electrophoresis 2001, 22:3043-3052.
12. Sharov V.G., Sabbah H.N., Shimoyama H., Ali A.S., Levine T.B., Lesch M., et al. Abnormalities of contractile structures in viable myocytes of the failing heart. Int J Cardiol 1994, 43:287-297.
13. Benjamin I.J., McMillan D.R. Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease. Circ Res 1998, 83:117-132.
14. Toko H., Minamino T., Komuro I. Role of heat shock transcriptional factor 1 and heat shock proteins in cardiac hypertrophy. Trends Cardiovasc Med 2008, 18:88-93.
15. Brundel B.J., Ke L., Dijkhuis A.J., Qi X., Shiroshita-Takeshita A., Nattel S., et al. Heat shock proteins as molecular targets for intervention in atrial fibrillation. Cardiovasc Res 2008, 78:422-428.
16. Liu L., Zhang X.J., Jiang S.R., Ding Z.N., Ding G.X., Huang J., et al. Heat shock protein 27 regulates oxidative stress-induced apoptosis in cardiomyocytes: mechanisms via reactive oxygen species generation and Akt activation. Chin Med J 2007, 120:2271-2277.
17. Venkatakrishnan C.D., Tewari A.K., Moldovan L., Cardounel A.J., Zweier J.L., Kuppusamy P., et al. Heat shock protects cardiac cells from doxorubicin-induced toxicity by activating p38 MAPK and phosphorylation of small heat shock protein 27. Am J Physiol Heart Circ Physiol 2006, 291:H2680-H2691.
18. Dohke T., Wada A., Isono T., Fujii M., Yamamoto T., Tsutamoto T., et al. Proteomic analysis reveals significant alternations of cardiac small heat shock protein expression in congestive heart failure. J Card Fail 2006, 12:77-84.
19. Brundel B.J., Shiroshita-Takeshita A., Qi X., Yeh Y.H., Chartier D., van Gelder I.C., et al. Induction of Heat Shock Response Protects the Heart Against Atrial Fibrillation. Circ Res 2006, 99:1394-1402.
20. Concannon C.G., Gorman A.M., Samali A. On the role of Hsp27 in regulating apoptosis. Apoptosis 2003, 8:61-70.
21. Li D., Shinagawa K., Pang L., Leung T.K., Cardin S., Wang Z., et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 2001, 104:2608-2614.
22. Toga W., Tanonaka K., Takeo S. Changes in Hsp60 level of the failing heart following acute myocardial infarction and the effect of long-term treatment with trandolapril. Biol Pharm Bull 2007, 30:105-110.
23. Maloyan A., Sanbe A., Osinska H., Westfall M., Robinson D., Imahashi K., et al. Mitochondrial dysfunction and apoptosis underlie the pathogenic process in alpha-B-crystallin desmin-related cardiomyopathy. Circulation 2005, 112:3451-3461.
24. Mayr M., Yusuf S., Weir G., Chung Y.L., Mayr U., Yin X., et al. Combined metabolomic and proteomic analysis of human atrial fibrillation. J Am Coll Cardiol Feb 5 2008, 51:585-594.
25. Satoh M., Shimoda Y., Akatsu T., Ishikawa Y., Minami Y., Nakamura M. Elevated circulating levels of heat shock protein 70 are related to systemic inflammatory reaction through monocyte Toll signal in patients with heart failure after acute myocardial infarction. Eur J Heart Fail 2006, 8:810-815.
26. Oc M., Ucar H.I., Pinar A., Akbulut B., Oc B., Akyon Y., et al. Heat shock protein70: a new marker for subsequent atrial fibrillation development?. Artif Organs 2008, 32:846-850.
27. Wakisaka O., Takahashi N., Shinohara T., Ooie T., Nakagawa M., Yonemochi H., et al. Hyperthermia treatment prevents angiotensin II-mediated atrial fibrosis and fibrillation via induction of heat-shock protein 72. J Mol Cell Cardiol 2007, 43:616-626.
28. Sakabe M., Shiroshita-Takeshita A., Maguy A., Brundel B.J., Fujiki A., Inoue H., et al. Effects of a heat shock protein inducer on the atrial fibrillation substrate caused by acute atrial ischaemia. Cardiovasc Res 2008, 78:63-70.
29. Costa V.M., Silva R., Tavares L.C., Vitorino R., Amado F., Carvalho F., et al. Adrenaline and reactive oxygen species elicit proteome and energetic metabolism modifications in freshly isolated rat cardiomyocytes. Toxicology 2009, 260:84-96.
30. Kim Y.M., Guzik T.J., Zhang Y.H., Zhang M.H., Kattach H., Ratnatunga C., et al. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res 2005, 97:629-636.
31. Shimano M., Shibata R., Inden Y., Yoshida N., Uchikawa T., Tsuji Y., et al. Reactive oxidative metabolites are associated with atrial conduction disturbance in patients with atrial fibrillation. Heart Rhythm 2009, 6:935-940.
32. Goette A., Bukowska A., Dobrev D., Pfeiffenberger J., Morawietz H., Strugala D., et al. Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles. Eur Heart J 2009, 30:1411-1420.
33. Lin P.H., Lee S.H., Su C.P., Wei Y.H. Oxidative damage to mitochondrial DNA in atrial muscle of patients with atrial fibrillation. Free Radic Biol Med 2003, 35:1310-1318.
34. Mihm M.J., Yu F., Carnes C.A., Reiser P.J., McCarthy P.M., Van Wagoner D.R., et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 2001, 104:174-180.
35. van Deel E.D., Lu Z., Xu X., Zhu G., Hu X., Oury T.D., et al. Extracellular superoxide dismutase protects the heart against oxidative stress and hypertrophy after myocardial infarction. Free Radic Biol Med 2008, 44:1305-1313.
36. Matsushima S., Ide T., Yamato M., Matsusaka H., Hattori F., Ikeuchi M., et al. Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 2006, 113:1779-1786.
37. Panagopoulou P., Davos C.H., Milner D.J., Varela E., Cameron J., Mann D.L., et al. Desmin mediates TNF-alpha-induced aggregate formation and intercalated disk reorganization in heart failure. J Cell Biol 2008, 181:761-775.
38. Barth A.S., Merk S., Arnoldi E., Zwermann L., Kloos P., Gebauer M., et al. Reprogramming of the human atrial transcriptome in permanent atrial fibrillation: expression of a ventricular-like genomic signature. Circ Res 2005, 96:1022-1029.
39. Cardin S., Pelletier P., Libby E., Le Bouter S., Xiao L., Kaab S., et al. Marked differences between atrial and ventricular gene-expression remodeling in dogs with experimental heart failure. J Mol Cell Cardiol 2008, 45:821-831.
40. Lai L.P., Lin J.L., Lin C.S., Yeh H.M., Tsay Y.G., Lee C.F., et al. Functional genomic study on atrial fibrillation using cDNA microarray and two-dimensional protein electrophoresis techniques and identification of the myosin regulatory light chain isoform reprogramming in atrial fibrillation. J Cardiovasc Electrophysiol 2004, 15:214-223.
41. Buck S.H., Konyn P.J., Palermo J., Robbins J., Moss R.L. Altered kinetics of contraction of mouse atrial myocytes expressing ventricular myosin regulatory light chain. Am J Physiol 1999, 276:H1167-H1171.
42. Pawloski-Dahm C.M., Song G., Kirkpatrick D.L., Palermo J., Gulick J., Dorn G.W., et al. Effects of total replacement of atrial myosin light chain-2 with the ventricular isoform in atrial myocytes of transgenic mice. Circulation 1998, 97:1508-1513.
43. Yeh Y.-H.W., Qi X.-Y., Chartier D., Boknik P., Kaab S., Ravens U., et al. Calcium-handling abnormalitied underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure. Circ Arrhythmia Electrophysiol 2008, 1:93-102.
44. Cha Y.M., Dzeja P.P., Shen W.K., Jahangir A., Hart C.Y., Terzic A., et al. Failing atrial myocardium: energetic deficits accompany structural remodeling and electrical instability. Am J Physiol Heart Circ Physiol 2003, 284:H1313-H1320.
45. Rardin M.J., Wiley S.E., Naviaux R.K., Murphy A.N., Dixon J.E. Monitoring phosphorylation of the pyruvate dehydrogenase complex. Anal Biochem 2009, 389:157-164.
46. Ausma J., Wijffels M., Thone F., Wouters L., Allessie M., Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 1997, 96:3157-3163.
47. Raha S., Robinson B.H. Mitochondria, oxygen free radicals, disease and ageing. Trends Biochem Sci 2000, 25:502-508.
48. Safer B. The Metabolic Significance of the Malate-Aspartate Cycle in Heart. Circ Res 1975, 37:527-533.
49. Crampin E.J., Smith N.P. A dynamic model of excitation-contraction coupling during acidosis in cardiac ventricular myocytes. Biophys J 2006, 90:3074-3090.
50. Page B., Young R., Iyer V., Suzuki G., Lis M., Korotchkina L., et al. Persistent regional downregulation in mitochondrial enzymes and upregulation of stress proteins in swine with chronic hibernating myocardium. Circ Res 2008, 102:103-112.
51. Robertson J.G., Barron L.L., Olson M.S. Effects of alpha-ketoisovalerate on bovine heart pyruvate dehydrogenase complex and pyruvate dehydrogenase kinase. J Biol Chem 1986, 261:76-81.
52. Recchia F.A., McConnell P.I., Bernstein R.D., Vogel T.R., Xu X., Hintze T.H. Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. Circ Res 1998, 83:969-979.
53. Schaffer S., Takahashi K., Azuma J. Role of osmoregulation in the actions of taurine. Amino Acids 2000, 19:527-546.
54. Allessie M., Ausma J., Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002, 54:230-246.
55. Cardin S., Li D., Thorin-Trescases N., Leung T.K., Thorin E., Nattel S. Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways. Cardiovasc Res 2003, 60:315-325.